Author's details
- Dr Taiwo Adedamola Alatise
- M.B.B.S (Ogb.), FWACP (Psych.)
- Consultant Psychiatrist, LAUTECH Teaching Hospital, Ogbomoso.
Reviewer's details
- Dr Mumeen Olaitan Salihu
- (MB;BS, FWACP, FMCPsych.)
- Consultant Psychiatrist, Kwara State University Teaching Hospital, Ilorin, Nigeria
- Date Uploaded: 2025-08-19
- Date Updated: 2025-08-19
Evaluation of Generalized Anxiety Disorder
Generalized Anxiety Disorder (GAD), also called freely floating anxiety, is a mental health condition characterized by persistent fear, feeling overwhelmed, and excessive worry about everyday routine and various aspects of life. These feelings can affect both children and adults and can be difficult to self-manage. Generalized anxiety disorder is common; it’s reported to affect about 3.3% to 5.6% of the Nigerian population, with higher rates recorded in urban areas and among women. Only a small percentage of those affected are receiving treatment, as many are unaware of the disorder. Additionally, anxiety symptoms are sometimes interpreted by society as moral or spiritual shortcomings, making it more difficult for the general public to recognize and treat GAD.
Aetiology/risk factors for GAD
- Genetics: GAD may run in families
- Personality: individual with timid or negative temperament may have increased risk of GAD
- Environmental factors such as negative or traumatic life events, separation during childhood, role inversion during childhood, lack of social interaction, poor life satisfaction, modelling of a relative having an anxiety disorder
- Chronic medical illnesses may increase the risk of GAD
Symptoms/presentations
The symptoms of GAD may vary, but they generally include emotional symptoms like persistent worry, anxiety, fear, and perceiving every situation as threatening; cognitive symptoms such as overthinking, fear of making wrong decisions, difficulty concentrating, and indecisiveness; and physical symptoms including trouble sleeping, restlessness, fatigue, muscle aches, diarrhea, and irritability. In many cases, somatic complaints such as headaches, body pains, and gastrointestinal disturbances are often common and may overshadow the emotional and cognitive symptoms.
Clinical Findings
Expected findings for Generalized anxiety disorder can be discovered through:
- Psychiatric Examination: Patients may experience trouble relaxing, excessive worry over trivial matters, feeling nervous or on edge, heightened state of alertness, and irritability.
- Physical Examination: Signs of muscle tension, trembling, restlessness, sweating, and fatigue might be observed
Diagnosis
- Excessive worry and anxiety occurring more days than not for atleast 6 months
- The individual finds it difficult to control the worry
- The worry and anxiety are associated with 3 or more symptoms from the followings; restlessness or feeling keyed up or an edge, difficulty concentrating or mind going blank, easy fatigability, irritability, muscle tension, and sleep disturbances.
Differential Diagnosis
Key conditions to rule out include:
Other Anxiety and Mood Disorders, such as panic disorder, anorexia nervosa, post-traumatic stress disorder, obsessive-compulsive disorder, and depression. Several medical conditions, like hyperthyroidism, schizophrenia, and substance-induced anxiety, including drug abuse and drug withdrawal, can also coexist with GAD.
Investigations
There are no specific laboratory or imaging tests for GAD. However, tests for thyroid function, blood, or urine may be carried out in cases of suspected medical conditions that could cause symptoms similar to anxiety. Urine Drug Toxicology Screening may be useful to rule out substance induced anxiety. Psychological screening tools such as the Generalized Anxiety Disorder-7 (GAD-7) scale, Hamilton Anxiety Scale (HAM-A) etc can also aid in diagnosis, assess severity and clinical improvement monitoring.
Treatment
The management involves psychotherapeutic, pharmacotherapeutic and supportive approaches; and the effective treatment is the one that combined the 3 approaches.
Psychotherapeutic: This includes Cognitive behavioral therapy, Supportive therapy, Insight- Oriented therapy, relaxation therapy, mindfulness therapies etc.
Pharmacotherapy: This involves the use of Selective serotonin reuptake inhibitors (such as sertraline and escitalopram), Benzodiazepines (usually used for a limited time due to risk of dependence), Buspirone, Venlafaxine.
Other drugs that may be useful includes TCAs (like imipramine), B-Adrenergic blockers to manage the somatic symptoms (Propanolol) The treatment of GAD may takes a duration of 6 months to 1 year or more.
Follow-Up
Consistent follow-up is important to mitigate symptom severity, enhance general functioning, and attain remission. The initial follow-up appointment should take place within 2-4 weeks of starting treatment, with subsequent visits at least every three months to track the course of the disorder. About 25% of patients relapse within 1 month of stopping the treatment while 60-80% relapse over the course of the next year.
Prevention and Control
GAD can be prevented and managed by; enlightening patients and the general public about anxiety disorders, particularly reassuring them that they are common and treatable; advising people to include self-directed activities and lifestyle modifications, such as journaling, yoga, mindfulness, meditation, good sleeping habits and other relaxation practices in their everyday life. o Routine screening for GAD and prompt treatment in primary care settings and the incorporation of mental health services into general healthcare can also serve as effective ways of mitigating the disorders.
Conclusion
Generalized anxiety disorder is a common mental health condition that causes constant worry in individuals and makes achieving daily goals overwhelming. Though the condition can be hard to manage if neglected over time or if a self-management approach is employed, with early diagnosis, proper coping mechanisms, therapy, and medications, the burden of the disorder can be reduced and significant improvement in quality in quality of life of affected persons
A middle-aged woman visited a primary health care clinic complaining of persistent headache, fatigue, and difficulty sleeping. She had previously received treatment for malaria and typhoid fever multiple times, but her condition did not improve. During her consultation with the clinician, she explained how she’s constantly worried about her family’s finances, and also mentioned having trouble concentrating and always feeling frustrated. After assessing her symptoms, the clinician diagnosed her with Generalized Anxiety Disorder (GAD). She was prescribed sertraline and referred to a therapist for cognitive-behavioral therapy. With proper treatment and regular follow-up, she began to feel better and eventually returned to her normal daily routines.
This case confirms that mental health conditions like GAD can often appear as physical health complaints, which is why it’s important to examine the individual as a whole, not just their symptoms, when making a diagnosis to provide effective care.
- Gureje, O., Lasebikan, V. O., Kola, L., & Makanjuola, V. A. (2010). Lifetime and 12-month prevalence of mental disorders in the Nigerian Survey of Mental Health and Well-Being. The British Journal of Psychiatry, 188(5), 465-471.
- Adewuya, A. O., Ola, B. A., & Afolabi, O. O. (2006). Validity of the patient health questionnaire (PHQ-9) as a screening tool for depression amongst Nigerian university students. Journal of Affective Disorders, 96(1-2), 89-93.
- Oladeji, B. D., & Gureje, O. (2013). The comorbidity between anxiety disorders and somatic non-communicable diseases in low- and middle-income countries. Current Opinion in Psychiatry, 26(1), 1-7.
- Kaplan & Sadocks, Synopsis of Psychiatry 11th Edition. Generalized Anxiety Disoder.

Author's details
Reviewer's details
Evaluation of Generalized Anxiety Disorder
- Background
- Symptoms
- Clinical findings
- Differential diagnosis
- Investigations
- Treatment
- Follow-up
- Prevention and control
- Further readings
Generalized Anxiety Disorder (GAD), also called freely floating anxiety, is a mental health condition characterized by persistent fear, feeling overwhelmed, and excessive worry about everyday routine and various aspects of life. These feelings can affect both children and adults and can be difficult to self-manage. Generalized anxiety disorder is common; it’s reported to affect about 3.3% to 5.6% of the Nigerian population, with higher rates recorded in urban areas and among women. Only a small percentage of those affected are receiving treatment, as many are unaware of the disorder. Additionally, anxiety symptoms are sometimes interpreted by society as moral or spiritual shortcomings, making it more difficult for the general public to recognize and treat GAD.
- Gureje, O., Lasebikan, V. O., Kola, L., & Makanjuola, V. A. (2010). Lifetime and 12-month prevalence of mental disorders in the Nigerian Survey of Mental Health and Well-Being. The British Journal of Psychiatry, 188(5), 465-471.
- Adewuya, A. O., Ola, B. A., & Afolabi, O. O. (2006). Validity of the patient health questionnaire (PHQ-9) as a screening tool for depression amongst Nigerian university students. Journal of Affective Disorders, 96(1-2), 89-93.
- Oladeji, B. D., & Gureje, O. (2013). The comorbidity between anxiety disorders and somatic non-communicable diseases in low- and middle-income countries. Current Opinion in Psychiatry, 26(1), 1-7.
- Kaplan & Sadocks, Synopsis of Psychiatry 11th Edition. Generalized Anxiety Disoder.

Content
Author's details
Reviewer's details
Evaluation of Generalized Anxiety Disorder
Background
Generalized Anxiety Disorder (GAD), also called freely floating anxiety, is a mental health condition characterized by persistent fear, feeling overwhelmed, and excessive worry about everyday routine and various aspects of life. These feelings can affect both children and adults and can be difficult to self-manage. Generalized anxiety disorder is common; it’s reported to affect about 3.3% to 5.6% of the Nigerian population, with higher rates recorded in urban areas and among women. Only a small percentage of those affected are receiving treatment, as many are unaware of the disorder. Additionally, anxiety symptoms are sometimes interpreted by society as moral or spiritual shortcomings, making it more difficult for the general public to recognize and treat GAD.
Further readings
- Gureje, O., Lasebikan, V. O., Kola, L., & Makanjuola, V. A. (2010). Lifetime and 12-month prevalence of mental disorders in the Nigerian Survey of Mental Health and Well-Being. The British Journal of Psychiatry, 188(5), 465-471.
- Adewuya, A. O., Ola, B. A., & Afolabi, O. O. (2006). Validity of the patient health questionnaire (PHQ-9) as a screening tool for depression amongst Nigerian university students. Journal of Affective Disorders, 96(1-2), 89-93.
- Oladeji, B. D., & Gureje, O. (2013). The comorbidity between anxiety disorders and somatic non-communicable diseases in low- and middle-income countries. Current Opinion in Psychiatry, 26(1), 1-7.
- Kaplan & Sadocks, Synopsis of Psychiatry 11th Edition. Generalized Anxiety Disoder.
Advertisement
